Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 1, 2014, Pages 221-228

  Kyung, Sun Young ^a   Byun, Kyung Hee ^a   Yoon, Jin Young ^a   Kim, Yu Jin ^a   Lee, Sang Pyo ^a   Park, Jeong Woong ^a   Lee, Bong Hee ^a   Park, Jong Sook ^b   Jang, An Soo ^b   Park, Choon Sik ^b   Jeong, Sung Hwan ^a  

^a Gachon University   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Advanced glycation end products; Idiopathic pulmonary fibrosis; Receptor for advanced glycation end product

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADVANCED GLYCATION END PRODUCTS; AGED; ARTICLE; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INTERSTITIAL LUNG DISEASE; MALE; METABOLISM; MIDDLE AGED; WESTERN BLOTTING;

ADVANCED GLYCATION END PRODUCTS; IDIOPATHIC PULMONARY FIBROSIS; RECEPTOR FOR ADVANCED GLYCATION END PRODUCT;

AGED; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC;

EID: 84891713712     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
2. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378: 1949-61.
3. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 2001; 85: 746-753.
4. Matsuse T, Ohga E, Teramoto S, Fukayama M, Nagai R, Horiuchi S, Ouchi Y. Immunohistochemical localization of advanced glycation end products in pulmonary fibrosis. J Clin Pathol 1998; 51: 515-519.
5. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation end products: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151.
6. Stitt AW, Vlassara H. Advanced glycation endproducts: impact on diabetic complications. In: Betteridge DJ, ed. Current Perspectives in diabetes. London: Martin Dunitz, 1999. pp: 67-92.
7. Giardino I, Edelstein D, Brownlee M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosy-lation in diabetes. J Clin Invest 1994; 94: 110-117.
8. D'Agati V, Yan SF, Ramasamy R, Schmidt AM. RAGE, glomerulosclerosis and proteinuria; Roles in podocytes and endothelial cells. Trends Endocrinol Metab 2010; 21: 50-56.
9. Englert JM, Kliment CR, Ramsgaard L, Milutinovic PS, Crum L, Tobolewski JM, Oury TD. Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis. Int J Clin Exp Pathol 2011; 4: 241-254.
10. Queisser MA, Kouri FM, Konigshoff M, Wygrecka M, Schubert U, Eickelberg O, Preissner KT. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol 2008; 39: 337-345.
11. Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, Fattman CL, Ramsgaard L, Richards TJ, Loutaev I, Nawroth PP, Kasper M, Bierhaus A, Oury TD. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 2008; 172: 583-591.
12. Buckley ST, Medina C, Kasper M, Ehrhardt C. Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2011; 300: L548-L559.
13. He M, Kubo H, Ishizawa K, Hegab A, Yamamoto Y, Yamamoto H, Yamaya M. The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1427-L1436.
14. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Modern Pathol 2006; 19: 1437-1445.
15. Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY. Role of receptor for advanced glycation end product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem J 2001; 81: 102-113.
16. Lee CI, Guh JY, Chen HC, Lin KH, Yang YL, Hung WC, Lai YH, Chuang LY. Leptin and connective tissue growth factor in advanced glycation end product-induced effects in NRK-49F cells. J Cell Biochem 2004; 93: 940-950.
17. Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol 2006; 126: 291-299.
18. Chen L, Wang T, Wang X, Sun BB, Li JQ, Liu DS, Zhang SF, Liu L, Xu D, Chen YJ, Wen FQ. Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats. Respir Res 2009; 10: 55.
19. Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 2006; 49: 2756-2762.
20. Kim YJ, Park JW, Kyung SY, Lee SP, Chung MP, Kim YH, Lee JH, Kim YC, Ryu JS, Lee HL, Park CS, Uh ST, Lee YC, Kim KH, Chun YJ, Park YB, Kim DS, Jegal Y, Lee JH, Park MS, Jeong SH. Clinical characteristics of idiopathic pulmonary fibrosis patients with diabetes mellitus: the national survey in korea from 2003 to 2007. J Korean Med Sci 2012; 27: 756-760
21. Yasuhiro A, Toshitaka M, Kana A, Manabu U, Fumiaki A, Nozomi A, Junichi N, Yoshichika S, Yuji S, Tatsuo S, Masashi A, Masahiko K. Pioglitazone,X a peroxisome proliferator- activated receptor gamma ligand, suppresses blemycin-induced acute lung injury and fibrosis. Respiration 2009; 77: 311-319
22. Mukherjee TK, Mukhopadhyay S, Hoidal JR. Implication of receptor for advanced end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 2008; 162: 210-215.
23. Hergrueter AH, Nguyen K, Owen CA. Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2011; 300: L512-L515.
24. Buckley ST, Ehrhardt C. The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol 2010; 2010: 917108.